These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1497689

  • 1. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
    Ganzinger U.
    Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W, Weiss M, Haase W.
    Curr Med Res Opin; 1984 Mar; 9(2):96-106. PubMed ID: 6443349
    [Abstract] [Full Text] [Related]

  • 5. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO.
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
    Zwinderman AH, Cleophas TJ, van der Sluijs H, Niemeyer MG, Buunk BP, van der Wall EE.
    Angiology; 1999 Dec; 50(12):963-9. PubMed ID: 10609762
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of effectiveness and tolerability of isosorbide mononitrate during a three-year period in patients with angina pectoris.
    May K, Eghbal B, Ahmadinejad M, Ensslin HD, Weiss M.
    Cardiology; 1991 Dec; 79 Suppl 2():46-50. PubMed ID: 1760829
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
    Yasky J, Ontanilla E, Koch JE.
    Cardiology; 1991 Dec; 79 Suppl 2():27-30. PubMed ID: 1760826
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH, O'Hara H, O'Hara J, Valle-Jones JC.
    Pharmatherapeutica; 1985 Dec; 4(6):367-75. PubMed ID: 3936056
    [Abstract] [Full Text] [Related]

  • 16. N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.
    Svendsen JH, Klarlund K, Aldershvile J, Waldorff S.
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):320-3. PubMed ID: 2468964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
    Martín Luengo C, Nieto Ballesteros F, Santos Rodríguez I, Diego Domínguez M, Fernández Esteban T, Avila Escribano C, Pavón Osuna P, Cascón Bueno M.
    An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
    van Hasselt M, Weiss M, Haase W.
    Curr Med Res Opin; 1984 Jan; 9(2):107-12. PubMed ID: 6443348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.